• 咨询热线
    客服服务热线 13671568941/15317326293
  • 在线咨询
  • 微信客服
    微信客服
  • 公众号
    扫码关注公众号

Minesapride

CAS No. 1184662-54-1

Minesapride ( —— )

产品货号. M34335 CAS No. 1184662-54-1

Minesapride, a novel 5-hydroxytryptamine 4 (5-HT4) receptor partial agonist, is a potential gastrointestinal prokinetic agent for the treatment of irritable bowel syndrome with constipation.

纯度: >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
规格 价格/人民币 库存 数量
2MG ¥2519 有现货
5MG ¥3472 有现货
10MG ¥5136 有现货
25MG ¥7718 有现货
50MG ¥10635 有现货
100MG ¥14000 有现货
500MG ¥28152 有现货
1G 获取报价 有现货

生物学信息

  • 产品名称
    Minesapride
  • 注意事项
    本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
  • 产品简述
    Minesapride, a novel 5-hydroxytryptamine 4 (5-HT4) receptor partial agonist, is a potential gastrointestinal prokinetic agent for the treatment of irritable bowel syndrome with constipation.
  • 产品描述
    Minesapride, a novel 5-hydroxytryptamine 4 (5-HT4) receptor partial agonist, is a potential gastrointestinal prokinetic agent for the treatment of irritable bowel syndrome with constipation.
  • 体外实验
    ——
  • 体内实验
    ——
  • 同义词
    ——
  • 通路
    GPCR/G Protein
  • 靶点
    5-HT Receptor
  • 受体
    5-HT Receptor
  • 研究领域
    ——
  • 适应症
    ——

化学信息

  • CAS Number
    1184662-54-1
  • 分子量
    454.95
  • 分子式
    C21H31ClN4O5
  • 纯度
    >98% (HPLC)
  • 溶解度
    ——
  • SMILES
    C(NC[C@H]1CN(CC2CCN(C(CO)=O)CC2)CCO1)(=O)C3=C(OC)C=C(N)C(Cl)=C3
  • 化学全称
    ——

运输与储存

  • 储存条件
    (-20℃)
  • 运输条件
    With Ice Pack
  • 稳定性
    ≥ 2 years

参考文献

产品手册
关联产品
  • Ticalopride

    Ticalopride is a 5-HT3 receptor agonist used in the treatment of digestive disorders, orofacial disorders, otorhinolaryngologic disorders, and may be used in the study of bulimia nervosa, gastroesophageal reflux, and irritable bowel syndrome.

  • Anpirtoline hydrochl...

    Anpirtoline hydrochloride 是anpirtoline 的一种盐酸化物。Anpirtoline 是 5-HT1B 的激动剂。

  • Seganserin

    Seganserin, a non-selective 5-hydroxytryptamine 2-HT receptor antagonist, reversed the inhibitory effects of fluoxetine and quipazine on luteinizing hormone-induced hyperphagia, depression and nociception, and reversed the antidepressant and analgesic effects induced by fluoxetine and quipazine.